Overview


According to FutureWise analysis the market for gastroesophageal reflux disease devices in 2023 is US$ 1.22 billion, and is expected to reach US$ 1.74 billion by 2031 at a CAGR of 4.52%.

GERD is a disorder in which the lower esophageal sphincter (LES) relaxes or fails to function properly, allowing stomach liquids to reflux back into the oesophagus and cause heartburn. GERD is caused by a number of causes including smoking, hiatal hernia, abdominal obesity, and stress. GERD can cause esophagitis (swelling of the oesophagus), Barrett's oesophagus (barrel disease), and ulcers if left untreated. The severity of the condition is used to create treatment modules. In many countries, increased rates of abdominal obesity, as well as unhealthy diets and lifestyles, are linked to an increase in the prevalence of GERD. The demand for gastroesophageal reflux disease devices will rise as a result of this. The prevalence of gastroesophageal reflux is not gender-specific; nevertheless, males are more likely to develop problems as a result of the disease. GERD is more common as people get older, especially after the age of 40. The difficulties related with esophageal motility and a decreased production of saliva are linked to esophageal dysfunction in the older population. As a result, the growing senior population will continue to drive the market for gastroesophageal reflux disease devices. One of the primary factors driving market expansion is the high rate of obesity in the United States.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Gastroesophageal Reflux Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Gastroesophageal Reflux Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  Addex Pharmaceuticals Ltd.
  •  Aros Pharma ApS
  •  AstraZeneca Plc.
  •  C. R. Bard, Inc.
  •  Eisai Co., Ltd.
  •  EndoGastric Solutions, Inc.
  •  KARL STORZ SECo. KG.
  •  MediGus Ltd.
  •  Olympus Corporation
  •  PENTAX Medical (Global)
  •  Pfizer Inc.
  •  Takeda Pharmaceutical Company Limited
  •  The Procter & Gamble Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  •  Diagnostic Devices
  •  Esophagoscopes and Gastroscopes
  •  Fundoplication Devices
  •  Manometry System
  •  PH Monitoring System
  •  Radiofrequency Ablation Devices
  •  Sphincter Augmentation Devices
  •  Treatment Devices
  •  Ultrasonic Surgical Endostapler

By Procedure Type

  •  Diagnostic Procedures
  •  Fundoplication Procedures
  •  Magnetic Sphincter Augmentation
  •  Radiofrequency Thermal Ablation

By Device Type

  •  Bravo Reflux Testing System
  •  Digitrapper reflux testing system
  •  LINX Management System
  •  MUSE -Medigus Ultrasonic Surgical Endostapler
  •  Others
  •  Stretta Therapy

By Surgery Type

  •  Invasive
    •  Linx Reflux Management
    •  Medigus Ultrasonic Surgical Endostapler
  •  Non-invasive
    •  Endocinch Endolumminal gastroplication
    •  Endoscopic Plicator System
    •  EsophyX
    •  Plexiglas poly-methyl-methacrylate (PMMA) microspheres
    •  Stretta

By Route of Administration

  •  Oral
  •  Parenteral

By Dosage Form

  •  Liquid
  •  Solid

By End Users

  •  Government
  •  Hospitals
  •  Medical Practitioners
  •  Others

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Gastroesophageal Reflux Disease Devices Market By Product Type, By Procedure Type, By Device Type, By Surgery Type, By Route of Administration, By Dosage Form, By End Users and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Gastroesophageal Reflux Disease Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Gastroesophageal Reflux Disease Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Gastroesophageal Reflux Disease Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Gastroesophageal Reflux Disease Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Devices
        2. Esophagoscopes and Gastroscopes
        3. Fundoplication Devices
        4. Manometry System
        5. PH Monitoring System
        6. Radiofrequency Ablation Devices
        7. Sphincter Augmentation Devices
        8. Treatment Devices
        9. Ultrasonic Surgical Endostapler

  • 8.   Gastroesophageal Reflux Disease Devices Market, By Procedure Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostic Procedures
        2. Fundoplication Procedures
        3. Magnetic Sphincter Augmentation
        4. Radiofrequency Thermal Ablation

  • 9.   Gastroesophageal Reflux Disease Devices Market, By Device Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bravo Reflux Testing System
        2. Digitrapper reflux testing system
        3. LINX Management System
        4. MUSE -Medigus Ultrasonic Surgical Endostapler
        5. Others
        6. Stretta Therapy

  • 10.   Gastroesophageal Reflux Disease Devices Market, By Surgery Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Invasive
         1.1. Linx Reflux Management
         1.2. Medigus Ultrasonic Surgical Endostapler
        2. Non-invasive
         2.1. Endocinch Endolumminal gastroplication
         2.2. Endoscopic Plicator System
         2.3. EsophyX
         2.4. Plexiglas poly-methyl-methacrylate (PMMA) microspheres
         2.5. Stretta

  • 11.   Gastroesophageal Reflux Disease Devices Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Parenteral

  • 12.   Gastroesophageal Reflux Disease Devices Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Liquid
        2. Solid

  • 13.   Gastroesophageal Reflux Disease Devices Market, By End Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Government
        2. Hospitals
        3. Medical Practitioners
        4. Others

  • 14.   North America Gastroesophageal Reflux Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 15.   Latin America Gastroesophageal Reflux Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 16.   Europe Gastroesophageal Reflux Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 17.   Asia Pacific Gastroesophageal Reflux Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 18.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 19.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 20.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Addex Pharmaceuticals Ltd.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Aros Pharma ApS
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AstraZeneca Plc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. C. R. Bard, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eisai Co., Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. EndoGastric Solutions, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. KARL STORZ SECo. KG.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. MediGus Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Olympus Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. PENTAX Medical (Global)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. Pfizer Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
         12. Takeda Pharmaceutical Company Limited
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
         13. The Procter & Gamble Company
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 21.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 22.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients